Stay updated on Avapritinib in Advanced Mastocytosis Clinical Trial
Sign up to get notified when there's something new on the Avapritinib in Advanced Mastocytosis Clinical Trial page.

Latest updates to the Avapritinib in Advanced Mastocytosis Clinical Trial page
- Check4 days agoChange DetectedAn NIH announcement banner about website changes and updated terminology appeared above the page. The site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe footer’s site revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check32 days agoChange DetectedA 403 Forbidden error page is displayed for the study page, replacing the usual study record content. The previously visible study documents and details appear removed or inaccessible due to the error.SummaryDifference19%

- Check39 days agoChange DetectedThe page's revision tag was updated from Revision: v3.6.6 to Revision: v3.7.0, indicating a new build of the page without changes to the study information.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page revision tag was updated from v3.6.5 to v3.6.6, indicating a newer version of the page. The change represents an update to the page's revision history with a new version number.SummaryDifference0.0%

- Check60 days agoChange DetectedA new identifier '2017 ( U.S. NIH Grant/Contract )' was added to the PATHFINDER study's list of Other Study ID Numbers, indicating NIH-related funding/contract information associated with the trial.SummaryDifference0.0%

Stay in the know with updates to Avapritinib in Advanced Mastocytosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avapritinib in Advanced Mastocytosis Clinical Trial page.